Skip to main content
Erschienen in: Clinical & Experimental Metastasis 2/2017

03.02.2017 | Research Paper

Antimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation

verfasst von: Sathisha U. Venkateshaiah, Mallikarjuna S. Eswaraiah, Harish Nayaka M. Annaiah, Shylaja M. Dharmesh

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Melanoma is a malignant neoplasm of major concern because of its high mortality rate and failure of chemotherapy. Previously we have shown that galectin-3, a galactose specific lectin, plays a pivotal role in the initiation of metastasis. It was hypothesized that blocking galectin-3 with galactose rich dietary pectic polymer would inhibit metastasis. The current study analyzes the preventive effect and mode of action of a pectic polymer from Swallow Root (Decalepis hamiltonii) in a preventative study of B16F10 cells lung colonization. Matrix metalloproteinase (MMPs) activity was assayed by zymography. Apoptotic/proliferative markers and cytokines were analyzed by immunoassay. Results indicated ~88% inhibition of lung colonization by SRPP as compared to 60% by CPP and only 7% by GRPP. Further molecular analysis revealed that galectin-3 blockade was associated with down regulation of MMPs and NFκB. Activation of caspases supported the apoptotic effect of SRPP. Infiltration of inflammatory cells into the lung was evidenced by presence of CD11b+ cells and release of the pro-inflammatory cytokine-IL-17, indicating inflammation during the cancer cell colonization process. SRPP enhanced the release of IL-12 that enables the reduction of inflammation. Our data for the first time indicate the effective anti-metastatic effect of SRPP due to both galectin-3 blockade and immunomodulation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Goldsmith LA, Askin FB, Chang AE, Cohen C, Dutcher JP, Gilgor R, Swanson NA (1992) Diagnosis and treatment of early melanoma: NIH Consensus Development Panel on Early Melanoma. JAMA 268:1314–1319CrossRef Goldsmith LA, Askin FB, Chang AE, Cohen C, Dutcher JP, Gilgor R, Swanson NA (1992) Diagnosis and treatment of early melanoma: NIH Consensus Development Panel on Early Melanoma. JAMA 268:1314–1319CrossRef
2.
Zurück zum Zitat Chamelli J, Frances P, Noonan, Merlino G (2003) Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22:3099–3112CrossRef Chamelli J, Frances P, Noonan, Merlino G (2003) Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22:3099–3112CrossRef
3.
Zurück zum Zitat Friedmann PS, Gilchrest BA (1987) Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol 133:88–94CrossRefPubMed Friedmann PS, Gilchrest BA (1987) Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol 133:88–94CrossRefPubMed
4.
Zurück zum Zitat Kanavy HE, Gerstenblith MR (2011) Ultraviolet radiation and melanoma. Semin Cutan Med Surg 30:222–228CrossRefPubMed Kanavy HE, Gerstenblith MR (2011) Ultraviolet radiation and melanoma. Semin Cutan Med Surg 30:222–228CrossRefPubMed
5.
Zurück zum Zitat Hofmann UB, Westphal JR, Waas ET (1999) Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81:774–782CrossRefPubMedPubMedCentral Hofmann UB, Westphal JR, Waas ET (1999) Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81:774–782CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Herrmann J, Truck CW, Atchison RE (1993) Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline, glycine, tyrosine rich sequence with bacterial and tissue collagenase. J Biol Chem 208:26704–26711 Herrmann J, Truck CW, Atchison RE (1993) Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline, glycine, tyrosine rich sequence with bacterial and tissue collagenase. J Biol Chem 208:26704–26711
7.
Zurück zum Zitat Victor G, Prieto A, Alexandra (2006) Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res 12:6709–6715CrossRef Victor G, Prieto A, Alexandra (2006) Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res 12:6709–6715CrossRef
8.
Zurück zum Zitat Sathisha UV, Smitha J, Harish Nayaka MA (2007) Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources. Glycoconj J 24:497–507CrossRefPubMed Sathisha UV, Smitha J, Harish Nayaka MA (2007) Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources. Glycoconj J 24:497–507CrossRefPubMed
9.
Zurück zum Zitat Raz A, Lotan R (1987) Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6:433–452CrossRefPubMed Raz A, Lotan R (1987) Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6:433–452CrossRefPubMed
10.
Zurück zum Zitat Gao X, Zhi Y, Sun L, Peng X, Zhang T, Xue H, Tai G, Zhou Y (2013) The Inhibitory effects of a rhamnogalacturonan (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship. J Biol Chem 288:33953–33965CrossRefPubMedPubMedCentral Gao X, Zhi Y, Sun L, Peng X, Zhang T, Xue H, Tai G, Zhou Y (2013) The Inhibitory effects of a rhamnogalacturonan (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship. J Biol Chem 288:33953–33965CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Inohara R, Raz A (1987) Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J 11:527–532CrossRef Inohara R, Raz A (1987) Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J 11:527–532CrossRef
12.
Zurück zum Zitat Hansen MB, Nielsen SE, Berg K (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203–210CrossRefPubMed Hansen MB, Nielsen SE, Berg K (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203–210CrossRefPubMed
13.
Zurück zum Zitat Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28:350–356CrossRef Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28:350–356CrossRef
14.
Zurück zum Zitat Cristina MC, Vicente VO, Josefa YM (2005) Treatment of metastastic melanoma B16F10 by the flavonoids tangeretin, rutin and diosmin. J Agric Food Chem 53:6791–6797CrossRef Cristina MC, Vicente VO, Josefa YM (2005) Treatment of metastastic melanoma B16F10 by the flavonoids tangeretin, rutin and diosmin. J Agric Food Chem 53:6791–6797CrossRef
15.
Zurück zum Zitat Smitha Jayaram, Sabeeta Kapoor, Shylaja M Dharmesh (2015) Pectic polysaccharide from corn (Zea mays L.) effectively inhibited multistep mediated cancer cell growth and metastasis. Chem Biol Interact 235:63–75CrossRefPubMed Smitha Jayaram, Sabeeta Kapoor, Shylaja M Dharmesh (2015) Pectic polysaccharide from corn (Zea mays L.) effectively inhibited multistep mediated cancer cell growth and metastasis. Chem Biol Interact 235:63–75CrossRefPubMed
16.
Zurück zum Zitat Srikanta BM, Siddaraju MN, Shylaja M Dharmesh (2007) A novel phenol-bound pectic polysaccharide from Decalepis hamiltonii with multi-step ulcer preventive activity. World J Gastroenterol 13:5196–5207CrossRefPubMedPubMedCentral Srikanta BM, Siddaraju MN, Shylaja M Dharmesh (2007) A novel phenol-bound pectic polysaccharide from Decalepis hamiltonii with multi-step ulcer preventive activity. World J Gastroenterol 13:5196–5207CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Martinez C, Vicente V, Yanez M, Garcia JM, Canteras M, Alcaraz M (2005) Experimental model of pulmonary metastasis treatment with IFN alpha. Cancer Lett 225:75–83CrossRefPubMed Martinez C, Vicente V, Yanez M, Garcia JM, Canteras M, Alcaraz M (2005) Experimental model of pulmonary metastasis treatment with IFN alpha. Cancer Lett 225:75–83CrossRefPubMed
18.
Zurück zum Zitat Lentini A, Autuoria F, Mattiolia P, Caragliab M, Abbruzzeseb A, Beninati S (2000) Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. Eur J Cancer 36:1572–1577CrossRefPubMed Lentini A, Autuoria F, Mattiolia P, Caragliab M, Abbruzzeseb A, Beninati S (2000) Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. Eur J Cancer 36:1572–1577CrossRefPubMed
19.
Zurück zum Zitat Brown ER, Doig T, Anderson N, Brenn T, Doherty V, Xu Y, Bartlett JM, Smyth JF, Melton DW (2012) Association of galectin-3 expression with melanoma progression and prognosis. Eur J Cancer 48:865–874CrossRefPubMed Brown ER, Doig T, Anderson N, Brenn T, Doherty V, Xu Y, Bartlett JM, Smyth JF, Melton DW (2012) Association of galectin-3 expression with melanoma progression and prognosis. Eur J Cancer 48:865–874CrossRefPubMed
20.
Zurück zum Zitat Balasubramanian K, Vasudevamurthy R, Sathisha UV (2009) Galectin-3 in urine of cancer patients: stage and tissue specificity. J Cancer Res Clin Oncol 135:355–363CrossRefPubMed Balasubramanian K, Vasudevamurthy R, Sathisha UV (2009) Galectin-3 in urine of cancer patients: stage and tissue specificity. J Cancer Res Clin Oncol 135:355–363CrossRefPubMed
21.
Zurück zum Zitat Shiu-Chen H, Chi-Tang H, Shoei-Yn L (2005) Carnosol inhibits the invasion of B16F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun. Biochem Pharma 69:221–232CrossRef Shiu-Chen H, Chi-Tang H, Shoei-Yn L (2005) Carnosol inhibits the invasion of B16F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun. Biochem Pharma 69:221–232CrossRef
22.
Zurück zum Zitat Powell AA, LaRue JM Martinez JD (2001) Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HT 116 cells. Biochem J 356:481–486CrossRefPubMedPubMedCentral Powell AA, LaRue JM Martinez JD (2001) Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HT 116 cells. Biochem J 356:481–486CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hibino S, Shibuya M, Engbring JA, Mochizuki M, Nomizu M, Kleinman HK (2004) Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 64:4810–4816CrossRefPubMed Hibino S, Shibuya M, Engbring JA, Mochizuki M, Nomizu M, Kleinman HK (2004) Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 64:4810–4816CrossRefPubMed
24.
Zurück zum Zitat Hosoi J, Abe E, Suda T (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res 45:1474–1478PubMed Hosoi J, Abe E, Suda T (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res 45:1474–1478PubMed
25.
Zurück zum Zitat Siddaraju MN, Dharmesh SM (2006) A bioactive fraction from zingiber officinale and a process for the preparation thereof. US patent, US8158608 Siddaraju MN, Dharmesh SM (2006) A bioactive fraction from zingiber officinale and a process for the preparation thereof. US patent, US8158608
26.
Zurück zum Zitat Ochieng J, Fridman R, Nangia-Makker P (1994) Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. BioChemistry 33:14109–14114CrossRefPubMed Ochieng J, Fridman R, Nangia-Makker P (1994) Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. BioChemistry 33:14109–14114CrossRefPubMed
27.
Zurück zum Zitat Takenaka Y, Fukumori T, Yoshii T (2004) Nuclear export of phosphorylated galectin-3 regulates its anti-apoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 24:4395–4406CrossRefPubMedPubMedCentral Takenaka Y, Fukumori T, Yoshii T (2004) Nuclear export of phosphorylated galectin-3 regulates its anti-apoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 24:4395–4406CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Shathish K, Guruvayoorappan C (2014) Decalepis hamiltonii inhibits tumor progression and metastasis by regulating the inflammatory mediators and nuclear factor κB subunits. Integr Cancer Ther 13:141–151CrossRefPubMed Shathish K, Guruvayoorappan C (2014) Decalepis hamiltonii inhibits tumor progression and metastasis by regulating the inflammatory mediators and nuclear factor κB subunits. Integr Cancer Ther 13:141–151CrossRefPubMed
29.
Zurück zum Zitat Watson E (2013) Natural galectin-3 inhibitors from pectins are the next big thing in heart-healthy foods, says start-up. Breaking News on Food and Beverage Development, North America, 22 Mar 2013 Watson E (2013) Natural galectin-3 inhibitors from pectins are the next big thing in heart-healthy foods, says start-up. Breaking News on Food and Beverage Development, North America, 22 Mar 2013
30.
Zurück zum Zitat Azemar M, Hildenbrand B, Haering B, Heim ME, Unger C (2007) Clinical benefit in patients with advanced solid tumors treated with modified citrus pectin: a prospective pilot study. Clin Med Oncol 1:73–80 Azemar M, Hildenbrand B, Haering B, Heim ME, Unger C (2007) Clinical benefit in patients with advanced solid tumors treated with modified citrus pectin: a prospective pilot study. Clin Med Oncol 1:73–80
31.
Zurück zum Zitat Pienta KJ, Naik H, Akhtar A et al (1995) Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst 87:348–353CrossRefPubMed Pienta KJ, Naik H, Akhtar A et al (1995) Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst 87:348–353CrossRefPubMed
32.
Zurück zum Zitat Nangia-Makker P, Hogan V, Honjo Y et al (2002) Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 94:1854–1862CrossRefPubMed Nangia-Makker P, Hogan V, Honjo Y et al (2002) Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 94:1854–1862CrossRefPubMed
33.
34.
Zurück zum Zitat Maxwell EG, Belshaw NJ, Waldron KW, Morris VJ (2012) Pectin-an emerging new bioactive food polysaccharide. Trends Food Sci Tech 24:64–73CrossRef Maxwell EG, Belshaw NJ, Waldron KW, Morris VJ (2012) Pectin-an emerging new bioactive food polysaccharide. Trends Food Sci Tech 24:64–73CrossRef
35.
Zurück zum Zitat Redman JM, Gibney GT, Atkins MB (2016) Advances in immunotherapy for melanoma. BMC Med 14(1):1CrossRef Redman JM, Gibney GT, Atkins MB (2016) Advances in immunotherapy for melanoma. BMC Med 14(1):1CrossRef
36.
Zurück zum Zitat Zhang L, Wang P, Qin Y, Cong Q, Shao C, Du Z, Ni X, Li P, Ding K (2016) RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. Oncogene. doi:10.1038/onc.2016.306 Zhang L, Wang P, Qin Y, Cong Q, Shao C, Du Z, Ni X, Li P, Ding K (2016) RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. Oncogene. doi:10.​1038/​onc.​2016.​306
37.
Zurück zum Zitat Menachem A, Bodner O, Pastor J, Raz A, Kloog Y (2015) Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors. Cell Death Discov 1:15047CrossRefPubMedPubMedCentral Menachem A, Bodner O, Pastor J, Raz A, Kloog Y (2015) Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors. Cell Death Discov 1:15047CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Platt D, Raz A (1992) Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Nat Cancer Inst 84:438–442CrossRefPubMed Platt D, Raz A (1992) Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Nat Cancer Inst 84:438–442CrossRefPubMed
39.
Zurück zum Zitat Zhang T, Zheng Y, Zhao D, Yan J, Sun C, Zhou Y, Tai G (2016) Multiple approaches to assess pectin binding to galectin-3. Int J Biol Macromol 91:994–1001CrossRefPubMed Zhang T, Zheng Y, Zhao D, Yan J, Sun C, Zhou Y, Tai G (2016) Multiple approaches to assess pectin binding to galectin-3. Int J Biol Macromol 91:994–1001CrossRefPubMed
40.
Zurück zum Zitat Zhang T, Lan Y, Zheng Y, Liu F, Zhao D, Mayo KH, Zhou Y, Tai G (2016) Identification of the bioactive components from pH-modified citrus pectin and their inhibitory effects on galectin-3 function. Food Hydrocoll 58:113–119CrossRef Zhang T, Lan Y, Zheng Y, Liu F, Zhao D, Mayo KH, Zhou Y, Tai G (2016) Identification of the bioactive components from pH-modified citrus pectin and their inhibitory effects on galectin-3 function. Food Hydrocoll 58:113–119CrossRef
41.
Zurück zum Zitat Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5:29–41CrossRefPubMed Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5:29–41CrossRefPubMed
42.
Zurück zum Zitat Kim K, Mayer EP, Nachtigal M (2003) Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins. Biochim Biophys Acta (BBA) 1641(1):13–23CrossRef Kim K, Mayer EP, Nachtigal M (2003) Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins. Biochim Biophys Acta (BBA) 1641(1):13–23CrossRef
43.
Zurück zum Zitat Bugelski PJ, Kirsh RL, Sowinski JM, Poste G (1985) Changes in the macrophage content of lung metastases at different stages in tumor growth. Am J Pathol 118(3):419PubMedPubMedCentral Bugelski PJ, Kirsh RL, Sowinski JM, Poste G (1985) Changes in the macrophage content of lung metastases at different stages in tumor growth. Am J Pathol 118(3):419PubMedPubMedCentral
45.
Zurück zum Zitat Tugues S, Burkhard SH, Ohs I, Vrohlings M, Nussbaum K, Vom Berg J, Becher B (2015) New insights into IL-12-mediated tumor suppression. Cell Death Differ 22(2):237–246CrossRefPubMed Tugues S, Burkhard SH, Ohs I, Vrohlings M, Nussbaum K, Vom Berg J, Becher B (2015) New insights into IL-12-mediated tumor suppression. Cell Death Differ 22(2):237–246CrossRefPubMed
46.
Zurück zum Zitat Seder RA, Kelsall BL, Jankovic D (1996) Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 157(7):2745–2748PubMed Seder RA, Kelsall BL, Jankovic D (1996) Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 157(7):2745–2748PubMed
Metadaten
Titel
Antimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation
verfasst von
Sathisha U. Venkateshaiah
Mallikarjuna S. Eswaraiah
Harish Nayaka M. Annaiah
Shylaja M. Dharmesh
Publikationsdatum
03.02.2017
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 2/2017
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-017-9836-z

Weitere Artikel der Ausgabe 2/2017

Clinical & Experimental Metastasis 2/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.